Julia Kwape Mimi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Julia Kwape Mimi has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Abdulbasit Opeyemi Muili
Medical Student, Department of Medicine, Ladoke Akintola University of Technology, Ibadan, Oyo, Nigeria. Scientific Editor (incoming), IJMS
1 shared publication - Abdulmalik Opeyemi Adeyemo
Department of Medicine, College of Health Sciences, University of Ilorin, P.M.B. 1515, Ilorin, Nigeria
1 shared publication - Abdulrahman Awal Olalekan
Department of Medicine and Surgery, University of Ilorin, Ilorin, Nigeria
1 shared publication - Akinmeji Mbbs Ayodeji
Department of Medicine and Surgery, Olabisi Onabanjo University, Ogun, Nigeria
1 shared publication - Aminnah Oyesomi
Sudan International University, Khartoum, Sudan
1 shared publication Emmanuel Adetola Babalola
Faculty of Dentistry, College of Medicine, University of Ibadan, Ibadan, Nigeria
1 shared publication
Latest Publications
- Open Access
- 28 January 2025
- Published by Springer Nature in Discover Medicine
- Vol. 2 (1) , 1-15
Endovascular techniques in the management of Moyamoya disease: a comprehensive review of current therapeutic options
- 28 January 2025
- Published by Springer Nature in Discover Medicine
- Vol. 2 (1) , 1-15
Open AccessEndovascular techniques in the management of Moyamoya disease: a comprehensive review of current therapeutic options
- Open Access
- 17 July 2024
- Published by Springer Nature in Discover Medicine
- Vol. 1 (1) , 1-11
High-dose vitamin D supplementation in multiple sclerosis: a systematic review of clinical effects and future directions
Vitamin D deficiency is common in multiple sclerosis (MS) patients. This review explores the potential benefits and limitations of high-dose vitamin D supplementation in MS management. We reviewed relevant literature on the effects of high-dose vitamin D supplementation on relapse rates, disability progression, quality of life, and MRI markers of disease activity in MS patients. Additionally, we discussed the mechanisms by which vitamin D might influence MS, potential adverse effects, and future research directions. Studies suggest that high-dose vitamin D supplementation may reduce relapse rates and improve MRI markers of disease activity in MS. However, the evidence for its impact on disability progression and quality of life remains inconclusive. Vitamin D’s immunomodulatory properties are well-documented, and its potential for neuroprotection and neurogenesis warrants further investigation. High-dose vitamin D supplementation holds promise as a complementary or disease-modifying therapy for MS. However, further robust research is required to solidify its role in clinical practice. Exploring vitamin D’s multifaceted effects on the immune system, neuroprotection, and neurogenesis paves the way for novel therapeutic strategies to improve the lives of individuals with MS.
- 17 July 2024
- Published by Springer Nature in Discover Medicine
- Vol. 1 (1) , 1-11
Open AccessHigh-dose vitamin D supplementation in multiple sclerosis: a systematic review of clinical effects and future directions
Vitamin D deficiency is common in multiple sclerosis (MS) patients. This review explores the potential benefits and limitations of high-dose vitamin D supplementation in MS management. We reviewed relevant literature on the effects of high-dose vitamin D supplementation on relapse rates, disability progression, quality of life, and MRI markers of disease activity in MS patients. Additionally, we discussed the mechanisms by which vitamin D might influence MS, potential adverse effects, and future research directions. Studies suggest that high-dose vitamin D supplementation may reduce relapse rates and improve MRI markers of disease activity in MS. However, the evidence for its impact on disability progression and quality of life remains inconclusive. Vitamin D’s immunomodulatory properties are well-documented, and its potential for neuroprotection and neurogenesis warrants further investigation. High-dose vitamin D supplementation holds promise as a complementary or disease-modifying therapy for MS. However, further robust research is required to solidify its role in clinical practice. Exploring vitamin D’s multifaceted effects on the immune system, neuroprotection, and neurogenesis paves the way for novel therapeutic strategies to improve the lives of individuals with MS.